Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #547143 on NorthWest Biotherapeutics Inc (NWBO)
SkyLimit2022
12/10/22 6:27 PM
#547146 RE: dr_lowenstein #547143
“Blinatumomab was granted accelerated approval for the treatment of adults and children with B-cell precursor (BCP) acute lymphoblastic leukemia.” “In April 2020, the FDA approved selumetinib for pediatric patients, 2 years of age and older, with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas”
NASDAQ2020
02/06/23 1:30 PM
#565326 RE: dr_lowenstein #547143
02/06/24 10:15 PM
#670619 RE: dr_lowenstein #547143